Encompass Health Revenue Growth Rates (EHC), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Encompass Health Corporation  (NYSE: EHC)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

EHC's Revenue Growth by Quarter and Year

Encompass Health's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

EHC Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 1,597.40
1st Quarter March 1,586.60
FY 3,184.00

EHCs Annual Revenue
Encompass Health's Revenue in the fiscal year 2025 $ 5,935.20 millions
Encompass Health's Revenue in the fiscal year 2024 $ 5,373.20 millions
Encompass Health's Revenue in the fiscal year 2023 $ 4,801.20 millions
Encompass Health's Revenue in the fiscal year 2022 $ 4,348.60 millions
Encompass Health's Revenue in the fiscal year 2021 $ 5,121.60 millions




EHC Revenue second quarter 2026 Y/Y Growth Comment
Encompass Health Corporation achieved in the second quarter 2026, above Company average Revenue improvement of 9.58% year on year, to $ 1,597.40 millions.

Looking into second quarter 2026 results within Healthcare Facilities industry 24 other companies have achieved higher Revenue growth. While Encompass Health Corporation' s Revenue increase of 9.58% ranks overall at the positon no. 2272 in the second quarter 2026.


EHC Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - 9.94 % 12.69 % 109.55 %
3rd Quarter September - 9.36 % 11.94 % 10.78 %
2nd Quarter June 9.58 % 12.03 % 9.61 % -10.78 %
1st Quarter March 9.01 % 10.59 % 13.41 % -12.99 %
FY   - 10.46 % 11.91 % -

Financial Statements
Encompass Health's second quarter 2026 Revenue $ 1,597.40 millions EHC's Income Statement
Encompass Health's second quarter 2025 Revenue $ 1,457.70 millions Quarterly EHC's Income Statement


EHC Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - 4.54 % 4 % 3.31 %
3rd Quarter September - 1.36 % 3.83 % 1.67 %
2nd Quarter June 0.68 % 0.16 % -1.12 % 2.3 %
1st Quarter March 2.72 % 3.59 % 5.55 % 95.03 %
FY (Year on Year)   - 10.46 % 11.91 % -


Back to EHC Growth rate Comparisons >> Back to EHC Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #25
Healthcare Sector #331
Overall #2272

Revenue Y/Y Growth Statistics
High Average Low
31.46 % 8.11 % -23.46 %
(Dec 31 2015)   (Jun 30 2023)
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #25
Healthcare Sector #331
Overall #2272
Revenue Y/Y Growth Statistics
High Average Low
31.46 % 8.11 % -23.46 %
(Dec 31 2015)   (Jun 30 2023)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Encompass Health's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
95.03 % 0.76 % -100 %
(Mar 31 2023)  


EHC's II. Quarter Q/Q Revenue Comment
Encompass Health Corporation achieved in the II. Quarter 2026 below company average Revenue growth of 0.68% quarter on quarter, to $ 1,597.40 millions.

II. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the 0.16% in the II. Quarter a year ago.

Within Healthcare Facilities industry 18 other companies have achieved higher Revenue quarter on quarter growth. While Encompass Health's Revenue growth quarter on quarter, overall rank is 1673.


Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #19
Healthcare Sector #224
Overall #1673
Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #19
Healthcare Sector #224
Overall #1673
Revenue Q/Q Growth Statistics
High Average Low
95.03 % 0.76 % -100 %
(Mar 31 2023)  


EHC's II. Quarter Q/Q Revenue Comment
Encompass Health Corporation achieved in the II. Quarter 2026 below company average Revenue growth of 0.68% quarter on quarter, to $ 1,597.40 millions.

II. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the 0.16% in the II. Quarter a year ago.

Within Healthcare Facilities industry 18 other companies have achieved higher Revenue quarter on quarter growth. While Encompass Health's Revenue growth quarter on quarter, overall rank is 1673.


Encompass Health's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 6,206.10 $ 6,066.40 $ 5,935.20 $ 5,795.60 $ 5,669.10
Y / Y Revenue Growth (TTM) 9.47 % 10.05 % 10.46 % 11.13 % 11.8 %
Year on Year Revenue Growth Overall Ranking # 1335 # 402 # 1056 # 146 # 297
Seqeuential Revenue Change (TTM) 2.3 % 2.21 % 2.41 % 2.23 % 2.84 %
Seq. Revenue Growth (TTM) Overall Ranking # 2333 # 2202 # 1138 # 857 # 1479


Cumulative Revenue growth Comment
Assuming the Encompass Health's fiscal year would have ended in Jun 30 2026, Encompass Health would have reprted above average annual Revenue improvement of 9.47% year on year, of $ 6,206 millions.
This marks a slow-down of the companys growth trends and from the 10.05% rise in Mar 31 2026.

In the Healthcare sector 228 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 402 to 1335.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 25
Healthcare Sector # 229
Overall # 1335

Revenue TTM Y/Y Growth Statistics
High Average Low
31.46 %
 8.11 %
-23.46 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 25
Sector # 336
S&P 500 # 2333
Cumulative Revenue growth Comment
Assuming the Encompass Health's fiscal year would have ended in Jun 30 2026, Encompass Health would have reprted above average annual Revenue improvement of 9.47% year on year, of $ 6,206 millions.
This marks a slow-down of the companys growth trends and from the 10.05% rise in Mar 31 2026.

In the Healthcare sector 228 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 402 to 1335.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 25
Healthcare Sector # 229
Overall # 1335

Revenue TTM Y/Y Growth Statistics
High Average Low
31.46 %
8.11 %
-23.46 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 25
Sector # 336
S&P 500 # 2333




Other Revenue Growth
Healthcare Facilities Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
EHC's Revenue Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue rise for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Cvrx inc 16.77%$ 16.766 millions
Regeneron Pharmaceuticals Inc 16.73%$ 16.735 millions
Invo Fertility Inc 16.73%$ 16.732 millions
Pro dex Inc 16.65%$ 16.646 millions
Royalty Pharma Plc16.50%$ 16.499 millions
Acadia Pharmaceuticals Inc 16.40%$ 16.402 millions
Harvard Bioscience Inc 16.35%$ 16.352 millions
Alpha Pro Tech Ltd 15.76%$ 15.765 millions
Armata Pharmaceuticals Inc 15.72%$ 15.722 millions
Lifeward ltd 15.71%$ 15.706 millions
Novocure Limited15.60%$ 15.603 millions
Ufp Technologies Inc 15.56%$ 15.558 millions
Orthopediatrics Corp15.55%$ 15.551 millions
Jazz Pharmaceuticals Plc15.55%$ 15.548 millions
Alphatec Holdings Inc 15.35%$ 15.349 millions
Penumbra Inc14.90%$ 14.904 millions
Rockwell Medical inc 14.69%$ 14.687 millions
Sbc Medical Group Holdings Incorporated14.36%$ 14.363 millions
Nuwellis Inc 14.14%$ 14.145 millions
West Pharmaceutical Services Inc 13.89%$ 13.892 millions
Edwards Lifesciences Corporation13.66%$ 13.657 millions
Indivior Pharmaceuticals Inc 13.58%$ 13.576 millions
Talkspace Inc 13.56%$ 13.556 millions
Atricure Inc 13.38%$ 13.376 millions
Dexcom Inc 13.11%$ 13.105 millions
Sanara Medtech Inc 13.03%$ 13.028 millions
Bausch Health Companies Inc 12.73%$ 12.727 millions
Vertex Pharmaceuticals Inc12.45%$ 12.453 millions
Genedx Holdings Corp 12.30%$ 12.304 millions
Profound Medical Corp 12.30%$ 12.302 millions


About Encompass Health Revenue Growth Rates (EHC), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Encompass Health Corp (CIK 785161).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0000785161-26-000186
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Encompass Health Corp’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.